Colonial Trust Advisors’s Biohaven BHVN Stock Holding History

Colonial Trust Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$7.5K	–	715
2025 Q3	$7.5K	Buy	+500	New	+$7.28K	﹤0.01%	531

Other funds holding BHVN

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Colonial Trust Advisors's BHVN Position: Q4 2025 in Review

Colonial Trust Advisors sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 500 shares — an estimated $7.5K sold.

Colonial Trust Advisors first reported a position in BHVN in Q3 2025 and held it in 1 quarter. The position peaked at $7.5K in Q3 2025. 272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

Colonial Trust Advisors reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
Colonial Trust Advisors sold 500 Biohaven shares in Q4 2025, an estimated $7.5K.
Colonial Trust Advisors first reported a position in Biohaven in Q3 2025 and held it in 1 quarter.
Colonial Trust Advisors's Biohaven position peaked at $7.5K in Q3 2025.
272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Colonial Trust Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.